The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Health Care Select Sector SPDR

NYSE: XLV
Last

(U.S.) $72.21

Today's change+1.38 +1.95%
Updated August 27 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Health Care Select Sector SPDR

NYSE: XLV
Last

(U.S.) $72.21

Today's change+1.38 +1.95%
Updated August 27 4:00 PM -4GMT. Delayed by at least 15 minutes.

Health Care Select Sector SPDR up sharply

Health Care Select Sector SPDR closed up sharply Thursday, rallying (U.S.)$1.38 or 1.95% to (U.S.)$72.21. Shares have lost 2.37% over the last five days, but have gained 5.60% over the last year to date. This security has outperformed the S&P 500 by 14.07% during the last year.

Key company metrics

  • Open(U.S.) $71.75
  • Previous close(U.S.) $70.83
  • High(U.S.) $72.31
  • Low(U.S.) $70.69
  • Bid / Ask(U.S.) $71.85 / (U.S.) $72.33
  • YTD % change+5.60%
  • Volume18,653,665
  • Average volume (10-day)15,723,604
  • Average volume (1-month)11,650,847
  • Average volume (3-month)8,984,873
  • 52-week range(U.S.) $56.63 to (U.S.) $77.40
  • Beta0.80
  • Trailing P/E5.59×
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.96
  • Dividend yield1.33%
  • Trailing EPS(U.S.) $12.92
Updated August 27 4:00 PM -4GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+1,414.10%

Based on its net profit margin of 1,414.10%, Health Care Select Sector SPDR is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.88%Sector:FinancialsIndustry:Investment Trusts
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q2/2014Q4/2013Q2/2013
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Mar 31, 201403/31/2014Sep 30, 201309/30/2013Mar 31, 201303/31/2013
Revenue83746863
Total other revenue--------
Total revenue83746863
Gross profit--------
Total cost of revenue--------
Total operating expense7765
Selling / general / administrative7765
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total0000
Operating income76676358
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets8761,204663833
Other--------
Income before tax9521,271726891
Income after tax9521,271726891
Income tax, total0000
Net income9521,271726891
Total adjustments to net income--------
Net income before extra. items9521,271726891
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9521,271726891
Inc. avail. to common incl. extra. items9521,271726891
Diluted net income9521,271726891
Dilution adjustment--------
Diluted weighted average shares187163140155
Diluted EPS excluding extraordinary itemsvalue per share5.107.825.175.73
Dividends per sharevalue per share0.440.470.410.41
Diluted normalized EPSvalue per share0.410.410.450.38